Dana P. Goldman

Names

Identifer

Contact

Affiliations

• University of Southern California / Leonard D. Schaeffer Center for Health Policy and Economics (weight: 99%)
  • EDIRC entry
  • location:
• University of Southern California / Sol Price School of Public Policy (weight: 1%)
  • EDIRC entry
  • location:

Research profile

author of:

• Part D Formulary and Benefit Design as a Risk-Steering Mechanism (RePEc:aea:aecrev:v:101:y:2011:i:3:p:382-86)
  by Dana P. Goldman & Geoffrey F. Joyce & William B. Vogt
• The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare (RePEc:aea:aecrev:v:104:y:2014:i:5:p:230-33)
  by Dana P. Goldman & Peter R. Orszag
• Socioeconomic Differences in the Adoption of New Medical Technologies (RePEc:aea:aecrev:v:95:y:2005:i:2:p:234-237)
  by Dana Goldman & James P. Smith
• Integrated Insurance Design in the Presence of Multiple Medical Technologies (RePEc:aea:aecrev:v:97:y:2007:i:2:p:427-432)
  by Tomas J. Philipson & Dana Goldman
• Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? (RePEc:aea:aejpol:v:10:y:2018:i:1:p:113-52)
  by Mariana Carrera & Dana P. Goldman & Geoffrey Joyce & Neeraj Sood
• Patient Cost-Sharing and Healthcare Spending Growth (RePEc:aea:jecper:v:25:y:2011:i:2:p:47-68)
  by Katherine Baicker & Dana Goldman
• The Effects of Relative Food Prices on Obesity – Evidence from China: 1991-2006 (RePEc:ags:aawewp:58249)
  by Lu, Yang & Goldman, Dana
• Health Care Spending: Historical Trends and New Directions (RePEc:anr:reveco:v:8:y:2016:p:291-319)
  by Alice Chen & Dana Goldman
• The benefits of risk factor prevention in Americans aged 51 years and older (RePEc:aph:ajpbhl:10.2105/ajph.2009.172627_3)
  by Goldman, D.P. & Zheng, Y. & Girosi, F. & Michaud, P.-C. & Olshansky, S.J. & Cutler, D. & Rowe, J.W.
• Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data (RePEc:bea:papers:0111)
  by John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn
• Productivity Growth in Treating a Major Chronic Health Condition (RePEc:bea:papers:0112)
  by John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn
• Effect of Insurance on Mortality in an HIV-Positive Population in Care (RePEc:bes:jnlasa:v:96:y:2001:m:september:p:883-894)
  by Goldman D. P. & Bhattacharya J. & McCaffrey D. F. & Duan N. & Leibowitz A. A. & Joyce G. F. & Morton S. C.
• Geographic Variation in Health Care: The Role of Private Markets (RePEc:bin:bpeajo:v:41:y:2010:i:2010-01:p:325-361)
  by Tomas J. Philipson & Seth A. Seabury & Lee M. Lockwood & Dana P. Goldman & Darius N. Lakdawalla
• How Costly is Hospital Quality? A Revealed‐Preference Approach (RePEc:bla:jindec:v:59:y:2011:i:4:p:578-608)
  by John A. Romley & Dana P. Goldman
• Price Regulation in Secondary Insurance Markets (RePEc:bla:jrinsu:v:71:y:2004:i:4:p:643-675)
  by Jay Bhattacharya & Dana Goldman & Neeraj Sood
• A Theory of Health Disparities and Medical Technology (RePEc:bpj:bejeap:v:contributions.4:y:2005:i:1:n:8)
  by Goldman Dana P & Lakdawalla Darius N.
• The Costs of A Medicare Prescription Drug Benefit (RePEc:bpj:bejeap:v:topics.2:y:2002:i:1:n:3)
  by Goldman Dana P & Joyce Geoffrey F & Malkin Jesse Dylan
• Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall (RePEc:bpj:evoice:v:10:y:2013:i:1:p:39-43:n:1)
  by Goldman Dana P. & Leive Adam & Lakdawalla Darius
• The Future of US Health Care: Is Medicare Really Better at “Saving” Money? (RePEc:bpj:evoice:v:11:y:2014:i:1:p:7:n:2)
  by Edlin Aaron & Goldman Dana P. & Leive Adam A.
• Are Biopharmaceutical Budget Caps Good Public Policy? (RePEc:bpj:evoice:v:13:y:2016:i:1:p:27-42:n:1)
  by Goldman Dana P. & Lakdawalla Darius N. & Baumgardner James R. & Linthicum Mark T.
• Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000 (RePEc:bpj:evoice:v:5:y:2008:i:4:n:1)
  by Goldman Dana P & McFadden Daniel L
• Can the ACA Improve Population Health? (RePEc:bpj:evoice:v:7:y:2010:i:5:n:4)
  by Goldman Dana P & Lakdawalla Darius N
• Forum for Health Economics & Policy (RePEc:bpj:fhecpo)
  from De Gruyter as editor
• The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 (RePEc:bpj:fhecpo:v:13:y:2010:i:2:n:1)
  by Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana
• Medical Expenditure Measures in the Health and Retirement Study (RePEc:bpj:fhecpo:v:14:y:2011:i:3:n:4)
  by Goldman Dana P & Zissimopoulos Julie & Lu Yang
• A Reexamination of the Costs of Medical R&D Regulation (RePEc:bpj:fhecpo:v:15:y:2012:i:2:p:1-28:n:10)
  by Philipson Tomas J. & Sun Eric & Goldman Dana & Jena Anupam B.
• The Value of Diagnostic Testing in Personalized Medicine (RePEc:bpj:fhecpo:v:16:y:2013:i:2:p:121-133:n:6)
  by Goldman Dana P. & Lakdawalla Darius & Sood Neeraj & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Agus David & Jena Anupam B. & Philipson Tomas J.
• Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants (RePEc:bpj:fhecpo:v:17:y:2014:i:2:p:16:n:4)
  by Seabury Seth A. & Lakdawalla Darius N. & Goldman Dana P. & Walter Deborah & Hayes John & Gustafson Thomas & Shrestha Anshu
• Health and Health Care of Medicare Beneficiaries in 2030 (RePEc:bpj:fhecpo:v:18:y:2015:i:2:p:75-96:n:1)
  by Gaudette Étienne & Tysinger Bryan & Goldman Dana P. & Cassil Alwyn
• Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection (RePEc:bpj:fhecpo:v:19:y:2016:i:1:p:141-156:n:6)
  by Seabury Seth A. & Goldman Dana P. & Lakdawalla Darius N. & Gupta Charu N. & Khan Zeba M. & Chandra Amitabh & Philipson Tomas J.
• Disability Forecasts and Future Medicare Costs (RePEc:bpj:fhecpo:v:7:y:2004:n:4)
  by Bhattacharya Jayanta & Cutler David M. & Goldman Dana P. & Hurd Michael D. & Joyce Geoffrey F. & Lakdawalla Darius N. & Panis Constantijn W. A. & Shang Baoping
• Wage and Benefit Changes in Response to Rising Health Insurance (RePEc:bpj:fhecpo:v:8:y:2005:n:3)
  by Goldman Dana P & Sood Neeraj & Leibowitz Arleen
• Adverse Selection in Retiree Prescription Drug Plans (RePEc:bpj:fhecpo:v:9:y:2006:i:1:n:4)
  by Goldman Dana P & Joyce Geoffrey & Karaca-Mandic Pinar & Sood Neeraj
• The Value of Elderly Disease Prevention (RePEc:bpj:fhecpo:v:biomedical_research:y:2006:n:1)
  by Goldman Dana P & Cutler David M & Shang Baoping & Joyce Geoffrey F
• How The Growing Gap In Life Expectancy May Affect Retirement Benefits And Reforms (RePEc:cdl:econwp:qt35g3339z)
  by Charles, Kerwin & Coile, Courtney & Gale, William & Goldman, Dana & Lucas, Charles & Orszag, Peter & Sheiner, Louise & Tysinger, Bryan & Weil, David & Wolfers, Justin & Wong, Rebeca & Auerbach, Alan &
• How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms (RePEc:cdl:econwp:qt3rw6w0b9)
  by Auerbach, Alan J & Charles, Kerwin K & Coile, Courtney C & Gale, William & Goldman, Dana & Lee, Ronald & Lucas, Charles M & Orszag, Peter R & Sheiner, Louise M & Tysinger, Bryan & Weil, David N & Wolf
• The reallocation of compensation in response to health insurance premium increases (RePEc:eee:ecolet:v:88:y:2005:i:2:p:147-151)
  by Goldman, Dana P. & Sood, Neeraj & Leibowitz, Arleen
• Disentangling moral hazard and adverse selection in private health insurance (RePEc:eee:econom:v:222:y:2021:i:1:p:141-160)
  by Powell, David & Goldman, Dana
• Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products (RePEc:eee:heachp:2-825)
  by Goldman, Dana & Lakdawalla, Darius
• Market evidence of misperceived mortality risk (RePEc:eee:jeborg:v:72:y:2009:i:1:p:451-462)
  by Bhattacharya, Jay & Goldman, Dana & Sood, Neeraj
• The effects of benefit design and managed care on health care costs (RePEc:eee:jhecon:v:14:y:1995:i:4:p:401-418)
  by Goldman, Dana P. & Hosek, Susan D. & Dixon, Lloyd S. & Sloss, Elizabeth M.
• The link between public and private insurance and HIV-related mortality (RePEc:eee:jhecon:v:22:y:2003:i:6:p:1105-1122)
  by Bhattacharya, Jayanta & Goldman, Dana & Sood, Neeraj
• An economic evaluation of the war on cancer (RePEc:eee:jhecon:v:29:y:2010:i:3:p:333-346)
  by Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J.
• The value of medical and pharmaceutical interventions for reducing obesity (RePEc:eee:jhecon:v:31:y:2012:i:4:p:630-643)
  by Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H.
• Digesting the doughnut hole (RePEc:eee:jhecon:v:32:y:2013:i:6:p:1345-1355)
  by Joyce, Geoffrey F. & Zissimopoulos, Julie & Goldman, Dana P.
• The long-term impact of functional disability on hospitalization spending in Singapore (RePEc:eee:joecag:v:14:y:2019:i:c:s2212828x18300793)
  by Chen, Cynthia & Lim, Jue Tao & Chia, Ngee Choon & Wang, Lijia & Tysinger, Bryan & Zissimopoulos, Julie & Chong, Ming Zhe & Wang, Zhe & Koh, Gerald Choon Huat & Yuan, Jian-Min & Tan, Kelvin Bryan & Chi
• Can patient self-management explain the health gradient? revisited: A response to Maitra (RePEc:eee:socmed:v:70:y:2010:i:6:p:813-815)
  by Smith, James Patrick & Goldman, Dana
• The increasing value of education to health (RePEc:eee:socmed:v:72:y:2011:i:10:p:1728-1737)
  by Goldman, Dana & Smith, James P.
• Differences in health between Americans and Western Europeans: Effects on longevity and public finance (RePEc:eee:socmed:v:73:y:2011:i:2:p:254-263)
  by Michaud, Pierre-Carl & Goldman, Dana & Lakdawalla, Darius & Gailey, Adam & Zheng, Yuhui
• Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards (RePEc:eee:socmed:v:73:y:2011:i:8:p:1163-1168)
  by Hackbarth, Andrew D. & Romley, John A. & Goldman, Dana P.
• Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (RePEc:hka:wpaper:2019-054)
  by Rebecca Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius Lakdawalla
• Understanding the Economic Consequences of Shifting Trends in Population Health (RePEc:iza:izadps:dp4366)
  by Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H.
• International Differences in Longevity and Health and Their Economic Consequences (RePEc:iza:izadps:dp4367)
  by Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H.
• Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors (RePEc:kap:jrisku:v:61:y:2020:i:2:d:10.1007_s11166-020-09336-3)
  by Wändi Bruine de Bruin & Htay-Wah Saw & Dana P. Goldman
• Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data (RePEc:lvl:lacicr:1038)
  by Pierre-Carl Michaud & Darius Lakdawalla & Dana Goldman & Neeraj Sood & Ze Cong
• The Value of Medican and Pharmaceutical Interventions for Reducing Obesity (RePEc:lvl:lacicr:1109)
  by Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zhen & Adam H. Gailey
• International Differences in Longevity and Health and their Economic Consequences (RePEc:mcm:sedapp:254)
  by P.-C. Michaud & D. Goldman & D. Lakdawalla & A. Gailey & Y. Zheng
• Understanding the Economic Consequences of Shifting Trends in Population Health (RePEc:mcm:sedapp:255)
  by P.-C. Michaud & D. Goldman & D. Lakdawalla & Y. Zheng & A. Gailey
• Opinion: Measuring how countries adapt to societal aging (RePEc:nas:journl:v:115:y:2018:p:435-437)
  by Dana P. Goldman & Cynthia Chen & Julie Zissimopoulos & John W. Rowe & the Research Network on an Aging Society
• Economic Dimensions of Personalized and Precision Medicine (RePEc:nbr:nberbk:bern-13)
  by Ernst R. Berndt & Dana P. Goldman & John W. Rowe
• Frontiers in Health Policy Research, Volume 10 (RePEc:nbr:nberbk:cutl07-1)
  by David Cutler & Alan Garber & Dana Goldman
• Frontiers in Health Policy Research, volume 12 (RePEc:nbr:nberbk:cutl08-2)
  by David Cutler & Alan Garber & Dana Goldman
• Frontiers in Health Policy Research, volume 13 (RePEc:nbr:nberbk:cutl09-1)
  by David Cutler & Alan Garber & Dana Goldman & William Vogt
• Disability and Spending Growth (RePEc:nbr:nberch:11116)
  by Michael E. Chernew & Dana Goldman & Feng Pan
• Food Prices and the Dynamics of Body Weight (RePEc:nbr:nberch:11817)
  by Dana Goldman & Darius Lakdawalla & Yuhui Zheng
• The Effects of Product Liability Exemption in the Presence of the FDA (RePEc:nbr:nberch:11962)
  by Tomas J. Philipson & Eric Sun & Dana Goldman
• A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis (RePEc:nbr:nberch:13104)
  by Armando Franco & Dana P. Goldman & Adam Leive & Daniel McFadden
• Introduction to "Economic Dimensions of Personalized and Precision Medicine" (RePEc:nbr:nberch:13986)
  by Ernst R. Berndt & Dana P. Goldman & John W. Rowe
• Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data (RePEc:nbr:nberch:14275)
  by John A. Romley & Abe Dunn & Dana Goldman & Neeraj Sood
• Disability Forecasts and Future Medicare Costs (RePEc:nbr:nberch:9870)
  by Jayanta Bhattacharya & David M. Cutler & Dana P. Goldman & Michael D. Hurd & Geoffrey F. Joyce & Darius N. Lakdawalla & Constantijn W. A. Panis
• Wage and Benefit Changes in Response to Rising Health Insurance (RePEc:nbr:nberch:9875)
  by Dana P. Goldman & Neeraj Sood & Arleen Leibowitz
• Adverse Selection in Retiree Prescription Drug Plans (RePEc:nbr:nberch:9881)
  by Dana P. Goldman & Geoffrey Joyce & Pinar Karaca-Mandic & Neeraj Sood
• HIV Breakthroughs and Risk Sexual Behavior (RePEc:nbr:nberwo:10516)
  by Dana Goldman & Darius Lakdawalla & Neeraj Sood
• Wage and Benefit Changes in Response to Rising Health Insurance Costs (RePEc:nbr:nberwo:11063)
  by Dana Goldman & Neeraj Sood & Arleen Leibowitz
• Socioeconomic Differences in the Adoption of New Medical Technologies (RePEc:nbr:nberwo:11218)
  by Dana Goldman & James P. Smith
• Medical Expenditure Risk and Household Portfolio Choice (RePEc:nbr:nberwo:11818)
  by Dana Goldman & Nicole Maestas
• Integrated Insurance Design in the Presence of Multiple Medical Technologies (RePEc:nbr:nberwo:12870)
  by Dana Goldman & Tomas Philipson
• Criminal Prosecution and HIV-related Risky Behavior (RePEc:nbr:nberwo:12903)
  by Adeline Delavande & Dana Goldman & Neeraj Sood
• Prescription Drug Coverage and Elderly Medicare Spending (RePEc:nbr:nberwo:13358)
  by Baoping Shang & Dana P. Goldman
• How Costly Is Hospital Quality? A Revealed-Preference Approach (RePEc:nbr:nberwo:13730)
  by John A. Romley & Dana Goldman
• Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand (RePEc:nbr:nberwo:14619)
  by Dana Goldman & John A. Romley
• Price Variation in Markets with Homogeneous Goods: The Case of Medigap (RePEc:nbr:nberwo:14679)
  by Nicole Maestas & Mathis Schroeder & Dana Goldman
• Food Prices and the Dynamics of Body Weight (RePEc:nbr:nberwo:15096)
  by Dana Goldman & Darius Lakdawalla & Yuhui Zheng
• Understanding the Economic Consequences of Shifting Trends in Population Health (RePEc:nbr:nberwo:15231)
  by Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zheng & Adam Gailey
• International Differences in Longevity and Health and their Economic Consequences (RePEc:nbr:nberwo:15235)
  by Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Adam Gailey & Yuhui Zheng
• An Economic Evaluation of the War on Cancer (RePEc:nbr:nberwo:15574)
  by Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman
• The Effects of Product Liability Exemption in the Presence of the FDA (RePEc:nbr:nberwo:15603)
  by Tomas J. Philipson & Eric C. Sun & Dana Goldman
• Terminal Care and The Value of Life Near Its End (RePEc:nbr:nberwo:15649)
  by Tomas J. Philipson & Gary Becker & Dana Goldman & Kevin M. Murphy
• The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006 (RePEc:nbr:nberwo:15720)
  by Yang Lu & Dana Goldman
• Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician (RePEc:nbr:nberwo:19186)
  by Mariana Carrera & Dana Goldman & Geoffrey Joyce
• Health Care Spending: Historical Trends and New Directions (RePEc:nbr:nberwo:21501)
  by Alice Chen & Dana Goldman
• Disentangling Moral Hazard and Adverse Selection in Private Health Insurance (RePEc:nbr:nberwo:21858)
  by David Powell & Dana Goldman
• How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms (RePEc:nbr:nberwo:23329)
  by Alan J. Auerbach & Kerwin K. Charles & Courtney C. Coile & William Gale & Dana Goldman & Ronald Lee & Charles M. Lucas & Peter R. Orszag & Louise M. Sheiner & Bryan Tysinger & David N. Weil & Justin W
• Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (RePEc:nbr:nberwo:26292)
  by Rebecca Mary Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius N. Lakdawalla
• Are the Young Becoming More Disabled? (RePEc:nbr:nberwo:8247)
  by Darius Lakdawalla & Dana Goldman & Jay Bhattacharya
• Understanding Health Disparities Across Education Groups (RePEc:nbr:nberwo:8328)
  by Dana Goldman & Darius Lakdawalla
• The Link Between Public and Private Insurance and HIV-Related Mortality (RePEc:nbr:nberwo:9346)
  by Jay Bhattacharya & Dana Goldman & Neeraj Sood
• The Reallocation of Compensation in Response to Health Insurance Premium Increases (RePEc:nbr:nberwo:9540)
  by Dana P. Goldman & Neeraj Sood & Arleen Leibowitz
• Market Evidence of Misperceived Prices and Mistaken Mortality Risks (RePEc:nbr:nberwo:9863)
  by Jay Bhattacharya & Dana Goldman & Neeraj Sood
• The Fiscal Consequences of Trends in Population Health (RePEc:ntj:journl:v:63:y:2010:i:2:p:307-30)
  by Goldman, Dana & Michaud, Pierre-Carl & Lakdawalla, Darius & Zheng, Yuhui & Gailey, Adam & Vaynman, Igor
• HIV Breakthroughs and Risky Sexual Behavior (RePEc:oup:qjecon:v:121:y:2006:i:3:p:1063-1102.)
  by Darius Lakdawalla & Neeraj Sood & Dana Goldman
• Prescription Drug Coverage and Medicare Spending among U.S. Elderly* (RePEc:pal:gpprii:v:35:y:2010:i:4:p:539-567)
  by Baoping Shang & Dana Goldman
• How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms (RePEc:pal:gpprii:v:42:y:2017:i:3:d:10.1057_s41288-017-0057-0)
  by Alan J. Auerbach & Kerwin K. Charles & Courtney C. Coile & William Gale & Dana Goldman & Ronald Lee & Charles M. Lucas & Peter R. Orszag & Louise M. Sheiner & Bryan Tysinger & David N. Weil & Justin W
• The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older (RePEc:plo:pone00:0166103)
  by David B Agus & Étienne Gaudette & Dana P Goldman & Andrew Messali
• The association between observed mobility and quality of life in the near elderly (RePEc:plo:pone00:0182920)
  by Jason Shafrin & Jeff Sullivan & Dana P Goldman & Thomas M Gill
• Estimated prevalence of undiagnosed atrial fibrillation in the United States (RePEc:plo:pone00:0195088)
  by Mintu P Turakhia & Jason Shafrin & Katalin Bognar & Jeffrey Trocio & Younos Abdulsattar & Daniel Wiederkehr & Dana P Goldman
• Racial and ethnic disparities in medication adherence among privately insured patients in the United States (RePEc:plo:pone00:0212117)
  by Zhiwen Xie & Patricia St. Clair & Dana P Goldman & Geoffrey Joyce
• Geographic variation in the delivery of high-value inpatient care (RePEc:plo:pone00:0213647)
  by John Romley & Erin Trish & Dana Goldman & Melinda Beeuwkes Buntin & Yulei He & Paul Ginsburg
• Employee Responses to Health Insurance Premium Increases (RePEc:pra:mprapa:12004)
  by Goldman, Dana & Leibowitz, Arleen & Robalino, David
• Moral Hazard and Adverse Selection in Private Health Insurance (RePEc:ran:wpaper:wr-1032)
  by David Powell & Dana P. Goldman
• Medical Expenditure Risk and Household Portfolio Choice (RePEc:ran:wpaper:wr-325-1)
  by Dana P. Goldman & Nicole Maestas
• Price Variation in Markets with Homogeneous Goods The Case of Medigap (RePEc:ran:wpaper:wr-504)
  by Nicole Maestas & Mathis Schroeder & Dana P. Goldman
• Managed Care as a Public Cost-Containment Mechanism (RePEc:rje:randje:v:26:y:1995:i:summer:p:277-295)
  by Dana P. Goldman
• The Future of the Elderly Population Health Status: Filling a Knowledge Gap (RePEc:rtv:ceisrp:504)
  by Vincenzo Atella & Federico Belotti & Kim Daejung & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger
• The potential impact of comparative effectiveness research on U.S. Health Care expenditures (RePEc:spr:demogr:v:47:y:2010:i:1:p:s173-s190)
  by Daniella Perlroth & Dana Goldman & Alan Garber
• The economics of alternative payment models for pharmaceuticals (RePEc:spr:eujhec:v:22:y:2021:i:4:d:10.1007_s10198-021-01274-4)
  by Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla
• Do Statins Reduce the Health and Health Care Costs of Obesity? (RePEc:spr:pharme:v:33:y:2015:i:7:p:723-734)
  by Étienne Gaudette & Dana Goldman & Andrew Messali & Neeraj Sood
• Effect of COVID-19 vaccine allocation strategies on vaccination refusal: a national survey (RePEc:taf:jriskr:v:25:y:2022:i:9:p:1047-1054)
  by Wändi Bruine de Bruin & Aulona Ulqinaku & Dana P. Goldman
• Queuing for Surgery: Is the U.S. or Canada Worse Off? (RePEc:tpr:restat:v:82:y:2000:i:2:p:297-308)
  by Barton H. Hamilton & Vivian Ho & Dana P. Goldman
• Economic Dimensions of Personalized and Precision Medicine (RePEc:ucp:bknber:9780226611068)
  by None
• The Returns to Preventing Chronic Disease in Europe and the United States (RePEc:ucp:jhucap:doi:10.1086/718513)
  by Jeffrey C. Yu & Bryan C. Tysinger & Andrea Piano Mortari & Federico Belotti & Martha Ryan & Vincenzo Atella & Dana P. Goldman
• Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior (RePEc:ucp:jlawec:doi:10.1086/655806)
  by Adeline Delavande & Dana Goldman & Neeraj Sood
• Does age or life expectancy better predict health care expenditures? (RePEc:wly:hlthec:v:17:y:2008:i:4:p:487-501)
  by Baoping Shang & Dana Goldman
• Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA (RePEc:wly:hlthec:v:19:y:2010:i:10:p:1109-1116)
  by Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin
• Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA (RePEc:wly:hlthec:v:19:y:2010:i:12:p:1510-1510)
  by Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin
• Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research (RePEc:wly:hlthec:v:23:y:2014:i:3:p:359-373)
  by Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois
• Response To Epstein'S Comment On “Heterogeneity In Action” (RePEc:wly:hlthec:v:23:y:2014:i:3:p:376-378)
  by Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois
• The future of the elderly population health status: Filling a knowledge gap (RePEc:wly:hlthec:v:30:y:2021:i:s1:p:11-29)
  by Vincenzo Atella & Federico Belotti & Daejung Kim & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger
• Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context (RePEc:wly:hlthec:v:30:y:2021:i:s1:p:3-10)
  by Vincenzo Atella & Dana Goldman & Daniel McFadden
• Predicting quantity and quality of life with the Future Elderly Model (RePEc:wly:hlthec:v:30:y:2021:i:s1:p:52-79)
  by Duncan Ermini Leaf & Bryan Tysinger & Dana P. Goldman & Darius N. Lakdawalla
• Improved survival for individuals with common chronic conditions in the Medicare population (RePEc:wly:hlthec:v:30:y:2021:i:s1:p:80-91)
  by Dana P. Goldman & Benjamin G. Cohen & Jessica Y. Ho & Daniel L. McFadden & Martha S. Ryan & Bryan Tysinger
• Medical Expenditure Risk And Household Portfolio Choice (RePEc:wly:japmet:v:28:y:2013:i:4:p:527-550)
  by Dana Goldman & Nicole Maestas
• It Is Time For Universal Coverage Without Breaking The Bank (RePEc:wly:jpamgt:v:37:y:2018:i:1:p:182-188)
  by Dana P. Goldman & Kip Hagopian
• Medicare†For†All: Not Our Only Option For Universal Coverage (RePEc:wly:jpamgt:v:37:y:2018:i:1:p:195-198)
  by Dana P. Goldman & Kip Hagopian
• Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (RePEc:wly:jpamgt:v:39:y:2020:i:3:p:577-604)
  by Rebecca M. Myerson & Reginald D. Tucker‐Seeley & Dana P. Goldman & Darius N. Lakdawalla
• Can Patient Self-Management Help Explain the SES Health Gradient? (RePEc:wpa:wuwphe:0403004)
  by Dana P. Goldman & James P. Smith